0
Your cart

Your cart is empty

Books > Business & Economics > Business & management > Management & management techniques > Organizational theory & behaviour

Buy Now

Health Care Policy and Regulation (Hardcover, 1995 ed.) Loot Price: R2,949
Discovery Miles 29 490
Health Care Policy and Regulation (Hardcover, 1995 ed.): Thomas A. Abbott III

Health Care Policy and Regulation (Hardcover, 1995 ed.)

Thomas A. Abbott III

Series: Topics in Regulatory Economics and Policy, 20

 (sign in to rate)
Loot Price R2,949 Discovery Miles 29 490 | Repayment Terms: R276 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

5 care reforms. Part II: Price Regulation The second partofthis volume examines the role ofprice regulation in controlling health care costs. It contains three chapters. In chapter seven, I examine the alternatives for regulating pharmaceutical prices. In chapter eight, Jack Hadley examines the impactofvarious forms ofhospital price regulation; while in chapter nine, MarkPaulyexaminestheroleofpriceregulation incontrollingphysician fees. Chapter seven focuses on the issue of regulating pharmaceutical prices. There are two key issues examined in this paper. First, is there a clear need for price regulation, and second, can price regulation work in this industry? In response to the first question, I come to the conclusion that the proponents ofprice regulation have not really proven their case. Although the financial returns in the pharmaceu tical industry have been slightly higher than expected during the 1970s and 1980s, there is not overwhelming evidence of"price gouging" or excessive profits on the part of the industry. In response to the second question, the answer is clearly no. The traditional approaches to price regulation will not have the intended affect of eliminating excess profits from the industry while maintaining the incentives for research and development. First, rate-of-return regulation, the most natural approach, would result in many adverse incentives-includingexcessive investment in research and developmentinorderto inflatetheratebaseused tocalculatedtheallowablereturns."

General

Imprint: Springer
Country of origin: Netherlands
Series: Topics in Regulatory Economics and Policy, 20
Release date: 2001
First published: February 1995
Editors: Thomas A. Abbott III
Dimensions: 229 x 152 x 19mm (L x W x T)
Format: Hardcover
Pages: 261
Edition: 1995 ed.
ISBN-13: 978-0-7923-9540-9
Categories: Books > Business & Economics > Business & management > Management & management techniques > Organizational theory & behaviour
Books > Medicine > General issues > Health systems & services > General
LSN: 0-7923-9540-9
Barcode: 9780792395409

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners